Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Anaphylaxis Treatment Market Size From 2025 to 2034?

The market size for anaphylaxis treatment has witnessed robust growth in the past few years. It is projected to grow from a value of $6.19 billion in 2024 to $6.59 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. The substantial growth during the historical period is credited to a higher frequency of allergic reactions, greater awareness and understanding of anaphylaxis, increased accessibility of epinephrine auto-injectors, heightened public awareness and education, and enhanced training of healthcare professionals.

The market for anaphylaxis treatment is predicted to witness a robust expansion in the forthcoming years. The market size is anticipated to rise to$8.68 billion in 2029, with a compound annual growth rate (CAGR) of 7.1%. Reasons for growth during the predicted period can be linked to advances in biologic therapies, tailored treatment methods, worldwide emphasis on food safety, patient advocacy and empowerment, as well as improved emergency medical services. Key trends observed for the predicted period involve innovations in auto-injectors, the use of telemedicine for managing anaphylaxis, advancements in allergen immunotherapy, the emergence of biometric wearables for allergen detection, and partnerships in allergy research.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Anaphylaxis Treatment Market?

The increase in food allergies is anticipated to stimulate the growth of the anaphylaxis treatment market. Food allergy involves an immune response to proteins in food, and anaphylaxis treatment aids in mitigating severe allergic manifestations such asskin involvement, mucosal surface changes, respiratory issues, hypotension, and organ dysfunction. For example, the Centers for Disease Control and Prevention reported in January 2023 that in 2021, 31.8% of adults over the age of 18 reported having a food allergy, seasonal allergy, or eczema, with food allergies accounting for 6.2% of these cases. Furthermore, as of August 2024, the Food Standards Agency stated that between October 2021 and August 27, 2023, only about 5% of accidental reactions in the UK were reported, with 213 (or 72%) of these cases being food related and 208 (or 97.7%) affecting children and young people under 18. This data underlines the growing prevalence of food allergies, which in turn is fuelling the growth of the anaphylaxis treatment market.

Which Key Market Segments Comprise the Anaphylaxis Treatment Market and Drive Its Revenue Growth?

The anaphylaxis treatmentmarket covered in this report is segmented –

1) By Treatment: Epinephrine; Antihistamines; Steroids; Beta-antagonists; Other Treatments

2) By Product: Tablets; Capsules; Other Products

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

4) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications

Subsegments:

1) By Epinephrine: Auto-Injectors; Vials Or Syringes

2) By Antihistamines: Oral Antihistamines; Injectable Antihistamines

3) By Steroids: Oral Steroids; Injectable Steroids

4) By Beta-antagonists: Oral Beta-blockers; Injectable Beta-blockers

5) By Other Treatments: Corticosteroids; Intravenous Fluids; Other Supportive Treatments

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12105&type=smp

Which Areas Are Leading Regions in the Anaphylaxis Treatment Market Expansion Across the Globe?

North America was the largest region in the anaphylaxis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theAnaphylaxis Treatment Market Direction?

The trend of product enhancement is gaining traction in the anaphylaxis treatment market, with leading companies improving their offerings to maintain their market standing. An example of this was seen in April 2022, when Aquestive Therapeutics Inc., a pharmaceutical firm based in the United States, got a Fast Track approval from the Food and Drug Administration for AQST-109, a treatment for extreme allergic reactions, including anaphylaxis. The firm is progressing with the clinical trials of AQST-109, an unprecedented oral epinephrine product, evidenced to be as effective as autoinjectors like EpiPen and Auvi-Q in treating allergic emergencies, including anaphylaxis.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

How Is the Anaphylaxis Treatment Market Conceptually Defined?

Anaphylaxis treatment refers to the treatment of life-threatening allergic reactions to foods, insect stings, medications, and latex in which immediate administration of epinephrine is given to reverse the allergic reaction and stabilize the patient’s condition. Rapid medical treatment and comprehensive supportive care are required to effectively manage potentially life-threatening symptoms of anaphylaxis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12105

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model